Cargando…
Discovery through clinical sequencing in oncology
The molecular characterization of tumors now informs clinical cancer care for many patients. This advent of molecular oncology is driven by the expanding number of therapeutic biomarkers that can predict sensitivity to both approved and investigational agents. Beyond its role in driving clinical tri...
Autores principales: | Donoghue, Mark T.A., Schram, Alison M., Hyman, David M., Taylor, Barry S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985175/ https://www.ncbi.nlm.nih.gov/pubmed/35122052 http://dx.doi.org/10.1038/s43018-020-0100-0 |
Ejemplares similares
-
Precision oncology: Charting a path forward to broader deployment of genomic profiling
por: Schram, Alison M., et al.
Publicado: (2017) -
Picking the Right Patient for Human Epidermal Growth Factor Receptor 3–Targeted Therapy in Platinum-Resistant Ovarian Cancer
por: Schram, Alison M., et al.
Publicado: (2016) -
Genome doubling shapes the evolution and prognosis of advanced cancers
por: Bielski, Craig M., et al.
Publicado: (2018) -
Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology
por: Ji, Yan, et al.
Publicado: (2018) -
Canine osteosarcoma in comparative oncology: Molecular mechanisms through to treatment discovery
por: Simpson, Siobhan, et al.
Publicado: (2022)